Table 4.
Spectrum of α-thalassemia gene mutations in Arab countries
Country | Most frequent α-thalassemia gene mutations (reference) |
---|---|
Algeria | Among 153 blood donors screened for 10 α-thalassemic determinants: 2.9 % had the (−α3.7), 0.6 % the α2 initiation codon T>C (αNco1α), and the (α−5ntα), (−(α)20.5) and (− −MED-1) at 0.3 % each (Mesbah-Amroun et al. 2008) |
Bahrain | Among 97 α-thalassemia chromosomes, the most common was the (α poly A1α) (53 %), followed by (− α3.7) (32 %), (α−5ntα) (12 %), (− α4.2) (2 %) and (α poly A2α) (1 %). The cause of HbH disease is consistently (αpoly A1α/αpoly A1α), other genotypes are rare (Jassim et al. 2001) |
Among 410 umbilical cord blood samples, 9.5 % were identified as α thalassaemia. The percentage of the different genotypes detected was: 4.5 % for (−α/αα), 3 % for (−α/–α), 1.75 % for (− −/αα) and 0.25 % HbH disease (− −/− α). No cases of Hb Bart’s hydrops fetalis (− −/− −) were detected (Rizk et al. 2005) | |
Iraq | Among 51 individuals with unexplained hypochromia and/or microcytosis from the Dohuk region in northern Iraq, 51 % had the (−α3.7/αα), 23.5 % the (− −MED-I/α α), 9.8 % the (−α 3.7/–α 3.7) and 3.9 % the (−α4.2/αα), other genotypes were sporadic . On the other hand, all 9 HbH cases studied had the (−α3.7/− −MED-I) genotype (Al-Allawi et al. 2009) |
Jordan | Among 430 α-thalassemic patients investigated: 43 % had the (−α3,7), followed by the (αpolyA1α) in 31 %, the (α−5ntα) and the (− −MED-I) in 18 % and 7 % respectively. Among 33 patients with HbH disease 60.6 %, 15.1 %, 12.2 % and 12.2 % had the (α poly A1α/αpoly A1α), (αpoly A1α/− −MED-I), (−α3.7/− −MED-I) and (α−5ntα/− −MED-I), respectively (Abu-Ghoush 2008) |
Kuwait | Among 17 HbH patients 70.8 % had the (αpoly A1α/αpoly A1α), while 25 % had the (αpoly A1α/–α3.7)and 4.2 % were undetermined (Haider and Adekile 2005) |
Of the 30 chromosomes from 15 patients with HbH disease, 86.7 % carried the (αpolyA1α), 10 % had (−α3.7), and 3.3 % had the (α−5ntα) (Adekile et al. 1994) | |
Saudi Arabia | Among 41 patients suffering from microcytic, hypochromic anemia from the eastern province, the most common alpha determinant was the (−α3.7) in 64 % followed by the (αpoly A1α) in 41 % (Hellani et al. 2009) |
A study to determine the deletional forms of α-thalassemia revealed that the (−α/αα) varied between 9.6 and 38.8 %, while the (−α/–α) ranged from 5 to 12.7 % in various regions of the kingdom (El-Hazmi and Warsy 1999) | |
In Eastern region, it was found that 45 % carried the (−α3.7), while another 15 % had a non-deletional defect (ααT), later found to be (αpolyA1α) (Al-Awamy 2000; Higgs et al. 1983) | |
Tunisia | No α0-thal alleles were found among 304 blood samples. Among cord blood samples from northeastern region, the (−α3.7) was the most common defect (4.5 % allele frequency) followed by (αpoly A1α) in 1.8 %, while (α−5ntα) and the (−α4.2) in 0.9 % each (Zorai et al. 2002) |
Testing 20 index cases with Hb Barts at birth revealed that 35 % had the (−α3.7/αα), 25 % had the (α−5ntα/αα), 5 % (−α3.7/−α3.7), while αcd23GAG>stop, αcd119CCT>TCT and α+6C>G were carried by 5 % each. In 7 families with HbH: 5 had the genotype (αpoly A1α/αpoly A1α), two had the (−α3.7/− −MED-I) (Siala et al. 2008) | |
UAE | Among 418 consecutive cord blood samples: 33.5 % were (−α3.7/αα), 11 % were (−α3.7/−α3.7), 1.4 % (α−5ntα/αα), 1.2 % (−α4.2/αα), 0.7 % each for (αpolyA1α/αα) and (αCSα/αα). Other sporadic mutations included (αpolyA2α/αα). In 22 patients with HbH disease or HbH-like syndrome, 9 were (αpolyA1α/−α3.7), 6 were homozygous for the (αpolyA1α) mutation, 2 were homozygous for Hb CS, and 5 were compound heterozygous for either (αpolyA1α), (αCSα), (α−5ntα), or (− −MED-I), with the (−α3.7) (El-Kalla and Baysal 1998; Haj Khelil et al. 2010) |